5-Methoxypsoralen increases evening sleepiness in humans: Possible involvement of the melatonin secretion
The acute and short-term effect of 5-methoxypsoralen (5-MOP) on daytime sleepiness was investigated in 12 healthy subjects according to a double-blind cross-over design. 5-MOP (40 mg/day) or placebo was orally administered (one week each) at 16.00 h. 5-MOP significantly increases daytime sleppiness 4 to 5 h after administration without affecting the subsequent sleep efficiency and duration. We found a positive correlation between sleepiness and melatonin levels.
Our findings suggest that the melatonin secretion may play a role in the effect of 5-MOP on sleepiness in humans.
Key wordspsoralen melatonin sleepiness
- Arendt J, Borbely AA, Franey C, Wright J (1984) The effects of chronic, small doses of melatonin given in the late afternoon on fatigue in man: A preliminary study. Neurosci Lett 45: 317–321Google Scholar
- Cramer H, Rudolph J, Consbruch U, Kendel K (1974) On the effects of melatonin on sleep and behaviour in man. In: Costa, Gesta, Sandler (eds) Advances in biochemical psychopharmacology, vol 11. Raven Press NY, p 187Google Scholar
- Lieberman HR, Waldhauser F, Gardfield G, Lynch RJ, Wurtman RJ (1984) Effects of melatonin on human mood and performance. Brain Res 323: 201–207Google Scholar
- Souêtre E, Salvati E, Belugou JL, De Galeani B, Krebs B, Ortonne JP, Darcourt G (1987) 5-Methoxypsoralen increases the plasma melatonin levels in humans. J Invest Dermatol 89: 152–159Google Scholar
- Vollrath L, Semm P, Gammel G (1981) Sleep induction by intranasal application of melatonin. Adv Biosci 29: 327–330Google Scholar